Efficacy and Safety of Bromfenac Ophthalmic Solution

PHASE2CompletedINTERVENTIONAL

Enrollment

568

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

July 31, 2008

Conditions

Cataract Surgery

Interventions

DRUG

bromfenac ophthalmic solution

sterile opthalmic solution

Trial Locations (1)

ISTA Pharmaceuticals, Inc., Irvine

All Listed Sponsors

lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00585975 - Efficacy and Safety of Bromfenac Ophthalmic Solution | Biotech Hunter | Biotech Hunter